Cargando...
‘Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut’
CD39 and CD73 control cell immunity by hydrolyzing proinflammatory ATP and ADP (CD39) into AMP, subsequently converted into anti-inflammatory adenosine (CD73). By regulating the balance between effector and regulatory cells, these ectonucleotidases promote immune homeostasis in acute and chronic inf...
Gardado en:
| Publicado en: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8096647/ https://ncbi.nlm.nih.gov/pubmed/33460629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2021.114417 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|